English 
Spanish 
Throughout February, March And April, All Donations Made To Parasites Without Borders Will Be Matched By PWB And Donated To ASTMH
MicrobeTV Podcast
MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.
March 14, 2024
Vaccine Effectiveness Against Long COVID in Children | Impact of Vaccination on the Association of COVID-19 with Cardiovascular Diseases: An OpenSAFELY Cohort Study | The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic
March 7, 2024
Interim Effectiveness of Updated 2023–2024 COVID-19 Vaccines Against COVID-19 | Combined Protection of Vaccination and Nirmatrelvir-ritonavir in Adults |
Ivermectin for COVID-19 in Adults in the Community (PRINCIPLE): An Open, Randomised, Controlled, Adaptive Platform |
Cognition and Memory after COVID-19 in a Large Community Sample |
Prospective Memory Assessment Before and After Covid-19 |
What is the Impact of Long-term COVID-19 on Workers
February 29, 2024
Effectiveness of Nirmatrelvir-ritonavir on Severe Outcomes of COVID-19 in the Era of Vaccination | Randomized Controlled Trial of Molnupiravir SARS-CoV-2 Viral and Antibody Response | Spontaneous, Persistent, T cell–dependent IFN-γ Release in Patients | Blood–brain Barrier Disruption and Sustained Systemic Inflammation in Individuals |
Prevalence of Persistent SARS-CoV-2 in a Large Community Surveillance Study | Long Term Outcomes of Hyperbaric Oxygen Therapy in Post Covid Condition
February 22, 2024
Self-administered versus Clinician-performed BinaxNOW COVID Rapid Test: A Comparison of Accuracy |
The Impact of COVID-19 Vaccination Prior to SARS-CoV-2 Infection on Prevalence of Long COVID among a Population-based Probability Sample of Michiganders, 2020-2022 |
Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection |
Long-term risks of Respiratory Diseases in Patients Infected with SARS-CoV-2
February 15, 2024
Early Estimates of Nirsevimab Immunoprophylaxis Effectiveness against Hospital Admission |
Redirecting Antibody Responses from Egg-adapted Epitopes Following Repeat Vaccination |
Risk of Cardiovascular Events after Influenza | Risk of Death Following Chikungunya Virus Disease |
Comparative Effectiveness of Alternative Intervals Between First and Second Doses | Early Mortality After the First Dose of Coronavirus Disease
February 8, 2024
Estimating the Heritability of SARS-CoV-2 Susceptibility and COVID-19 Severity | Neonatal Outcomes After COVID-19 Vaccination in Pregnancy | Contralateral Second Dose Improves Antibody Responses to a Two-dose mRNA Vaccination
Regimen | Substantial Health and Economic Burden of COVID-19 During the Year After Acute Illness
Among US Adults Not at High Risk of Severe COVID-19
Situation Dashboards
World Health Organization (WHO)
Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
Johns Hopkins University (JHU)
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
COVID-19 in US and Canada
1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
Genomic Epidemiology COVID-19
Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.
